{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:32:23Z","timestamp":1792290743318,"version":"4.4.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.lpm.2024.104248","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T14:25:46Z","timestamp":1725632746000},"page":"104248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advancing the management of acute intermediate-high-risk pulmonary embolism: The enduring legacy of Professor Guy Meyer"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6359-7279","authenticated-orcid":false,"given":"Stavros V.","family":"Konstantinides","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1633-8391","authenticated-orcid":false,"given":"Olivier","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Z.","family":"Goldhaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Meneveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2024.104248_bib0001","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJM196405212702101","article-title":"Pulmonary angiography in the diagnosis of thromboembolic disease","volume":"270","author":"Sasahara","year":"1964","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2024.104248_bib0002","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/hrt.32.4.518","article-title":"Acute massive pulmonary embolism. Clinical and haemodynamic findings in 23 patients studied by cardiac catheterization and pulmonary arteriography","volume":"32","author":"Miller","year":"1970","journal-title":"Br Heart J"},{"key":"10.1016\/j.lpm.2024.104248_bib0003","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1001\/jama.1970.03180120035007","article-title":"Urokinase pulmonary embolism trial. Phase 1 results: a cooperative study","volume":"214","year":"1970","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2024.104248_bib0004","first-page":"II1","article-title":"The urokinase pulmonary embolism trial. A national cooperative study","volume":"47","year":"1973","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2024.104248_bib0005","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/bmj.1.5904.343","article-title":"Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonay embolism","volume":"1","author":"Tibbutt","year":"1974","journal-title":"Br Med J"},{"key":"10.1016\/j.lpm.2024.104248_bib0006","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1001\/jama.1974.03230500024021","article-title":"Urokinase-streptokinase embolism trial. Phase 2 results. A cooperative study","volume":"229","year":"1974","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2024.104248_bib0007","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(86)90411-3","article-title":"Acute pulmonary embolism treated with tissue plasminogen activator","volume":"2","author":"Goldhaber","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2024.104248_bib0008","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(88)92354-9","article-title":"Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism","volume":"2","author":"Goldhaber","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2024.104248_bib0009","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.CIR.77.2.353","article-title":"Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism","volume":"77","author":"Verstraete","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2024.104248_bib0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0735-1097(92)90472-Y","article-title":"Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism","volume":"19","author":"Meyer","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2024.104248_bib0011","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0735-1097(92)90002-5","article-title":"PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2","volume":"20","author":"Dalla-Volta","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2024.104248_bib0012","doi-asserted-by":"crossref","first-page":"45S","DOI":"10.1378\/chest.107.1_Supplement.45S","article-title":"Contemporary pulmonary embolism thrombolysis","volume":"107","author":"Goldhaber","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2024.104248_bib0013","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0140-6736(93)90274-K","article-title":"Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion","volume":"341","author":"Goldhaber","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2024.104248_bib0014","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2024.104248_bib0015","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0735-1097(92)90473-Z","article-title":"Pulmonary embolism thrombolysis: a clarion call for international collaboration","volume":"19","author":"Goldhaber","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2024.104248_bib0016","doi-asserted-by":"crossref","first-page":"313","DOI":"10.7326\/0003-4819-121-5-199409010-00001","article-title":"Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Consideration of noninvasive management","volume":"121","author":"Stein","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2024.104248_bib0017","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0002-8703(86)90361-3","article-title":"Echocardiographic findings in patients with proved pulmonary embolism","volume":"112","author":"Kasper","year":"1986","journal-title":"Am Heart J"},{"key":"10.1016\/j.lpm.2024.104248_bib0018","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/hrt.70.4.352","article-title":"Distinguishing between acute and subacute massive pulmonary embolism by conventional and Doppler echocardiography","volume":"70","author":"Kasper","year":"1993","journal-title":"Br Heart J"},{"key":"10.1016\/j.lpm.2024.104248_bib0019","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/hrt.77.4.346","article-title":"Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism","volume":"77","author":"Kasper","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.lpm.2024.104248_bib0020","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0735-1097(97)00319-7","article-title":"Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry","volume":"30","author":"Kasper","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2024.104248_bib0021","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0140-6736(98)07534-5","article-title":"Acute pulmonary embolism: clinical outcomes in the international cooperative pulmonary embolism registry (ICOPER)","volume":"353","author":"Goldhaber","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2024.104248_bib0022","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1161\/01.CIR.96.3.882","article-title":"Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry","volume":"96","author":"Konstantinides","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2024.104248_bib0023","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1053\/euhj.2000.2250","article-title":"Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology","volume":"21","author":"Torbicki","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2024.104248_bib0024","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMoa021274","article-title":"Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism","volume":"347","author":"Konstantinides","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2024.104248_bib0025","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/eurheartj\/ehn310","article-title":"Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)","volume":"29","author":"Torbicki","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2024.104248_bib0026","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1046\/j.1538-7836.2003.00343.x","article-title":"Thrombolysis in submassive pulmonary embolism?","volume":"1","author":"Dalen","year":"2003","journal-title":"No. J Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104248_bib0027","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/eurheartj\/ehn208","article-title":"Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review","volume":"29","author":"Sanchez","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2024.104248_bib0028","first-page":"795","article-title":"Acute pulmonary embolism revisited: thromboembolic venous disease","volume":"94","author":"Konstantinides","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.lpm.2024.104248_bib0029","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1183\/09031936.00211613","article-title":"Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism","volume":"43","author":"Lankeit","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2024.104248_bib0030","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1164\/rccm.201311-2040OC","article-title":"Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism","volume":"189","author":"Jimenez","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2024.104248_bib0031","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1164\/rccm.200906-0970OC","article-title":"Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study","volume":"181","author":"Sanchez","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"pii","key":"10.1016\/j.lpm.2024.104248_bib0032","article-title":"Prognostic value of right ventricular dilatation in patients with low-risk pulmonary embolism","volume":"50","author":"Cote","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2024.104248_bib0033","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/eurheartj\/ehu283","article-title":"2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: the task force for the diagnosis and management of acute pulmonary embolism of the european society of cardiology (ESC)endorsed by the European respiratory society (ERS)","volume":"35","author":"Konstantinides","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2024.104248_bib0034","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIR.0b013e318214914f","article-title":"Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association","volume":"123","author":"Jaff","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2024.104248_bib0035","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1056\/NEJMcp0804570","article-title":"Clinical practice. Acute pulmonary embolism","volume":"359","author":"Konstantinides","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2024.104248_bib0036","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2024.104248_bib0037","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/eurheartj\/ehu218","article-title":"Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis","volume":"36","author":"Marti","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2024.104248_bib0038","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American society of hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.lpm.2024.104248_bib0039","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2024.104248_bib0040","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.jacc.2016.12.039","article-title":"Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism","volume":"69","author":"Konstantinides","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2024.104248_bib0041","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.amjmed.2011.10.015","article-title":"Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused","volume":"125","author":"Stein","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2024.104248_bib0042","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.chest.2019.10.049","article-title":"Utilization and outcomes of thrombolytic therapy for acute pulmonary embolism: a nationwide cohort study","volume":"157","author":"Beyer","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2024.104248_bib0043","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/eurheartj\/ehz236","article-title":"Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany","volume":"41","author":"Keller","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2024.104248_bib0044","doi-asserted-by":"crossref","DOI":"10.1007\/s00392-024-02437-y","article-title":"Drivers and recent trends of hospitalisation costs related to acute pulmonary embolism","author":"Mohr","year":"2024","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.lpm.2024.104248_bib0045","doi-asserted-by":"crossref","first-page":"e774","DOI":"10.1161\/CIR.0000000000000707","article-title":"Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence: a scientific statement from the American heart association","volume":"140","author":"Giri","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2024.104248_bib0046","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41569-023-00876-0","article-title":"Interventional therapies for pulmonary embolism","volume":"20","author":"G\u00f6tzinger","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.lpm.2024.104248_bib0047","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1016\/j.jcin.2023.07.042","article-title":"Efficacy and safety of anticoagulation, catheter-directed thrombolysis, or systemic thrombolysis in acute pulmonary embolism","volume":"16","author":"Zhang","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.lpm.2024.104248_bib0048","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.amjcard.2023.07.170","article-title":"Comparative outcomes of catheter-directed thrombolysis plus systemic anticoagulation versus systemic anticoagulation alone in the management of intermediate-risk pulmonary embolism in a systematic review and meta-analysis","volume":"205","author":"Balakrishna","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.lpm.2024.104248_bib0049","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/clinpract12020024","article-title":"Prevalence, trends, and outcomes of pulmonary embolism treated with mechanical and surgical thrombectomy from a nationwide inpatient sample","volume":"12","author":"Raghupathy","year":"2022","journal-title":"Clin Pract"},{"key":"10.1016\/j.lpm.2024.104248_bib0050","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/ehjacc\/zuad092","article-title":"Temporal trends in the utilization of advanced therapies among patients with acute pulmonary embolism: insights from a national database","volume":"12","author":"Abumoawad","year":"2023","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.lpm.2024.104248_bib0051","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11239-018-1737-8","article-title":"Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis","volume":"47","author":"Rosovsky","year":"2019","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.lpm.2024.104248_bib0052","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00392-022-02077-0","article-title":"Pulmonary embolism response team (PERT) implementation and its clinical value across countries: a scoping review and meta-analysis","volume":"112","author":"Hobohm","year":"2023","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.lpm.2024.104248_bib0053","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.4244\/EIJ-D-22-00246","article-title":"Percutaneous treatment options for acute pulmonary embolism: a clinical consensus statement by the ESC working group on pulmonary circulation and right ventricular function and the European association of percutaneous cardiovascular interventions","volume":"18","author":"Pruszczyk","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.lpm.2024.104248_bib0054","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/ehjacc\/zuae019","article-title":"Modelling costs of interventional pulmonary embolism treatment: implications of US trends for a European healthcare system","volume":"13","author":"Mohr","year":"2024","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.lpm.2024.104248_bib0055","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1378\/chest.106.3.718","article-title":"Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group","volume":"106","author":"Goldhaber","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2024.104248_bib0056","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1378\/chest.106.3.712","article-title":"Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial","volume":"106","author":"Sors","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2024.104248_bib0057","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1378\/chest.09-0765","article-title":"Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial","volume":"137","author":"Wang","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2024.104248_bib0058","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.thromres.2013.12.026","article-title":"Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis","volume":"133","author":"Zhang","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.lpm.2024.104248_bib0059","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1378\/chest.98.6.1473","article-title":"A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism","volume":"98","author":"Levine","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2024.104248_bib0060","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1055\/a-1653-4699","article-title":"Reduced-dose intravenous thrombolysis for acute intermediate-high-risk pulmonary embolism: rationale and design of the pulmonary embolism international THrOmbolysis (PEITHO)-3 trial","volume":"122","author":"Sanchez","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104248_bib0061","first-page":"51","article-title":"Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials","author":"Barco","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2024.104248_bib0062","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ahj.2022.05.011","article-title":"Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: rationale and design of the HI-PEITHO study","volume":"251","author":"Klok","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.lpm.2024.104248_bib0063","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S2213-2600(19)30354-6","article-title":"Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database","volume":"8","author":"Barco","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.lpm.2024.104248_bib0064","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S2213-2600(20)30417-3","article-title":"Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO mortality database and of the CDC multiple cause of death database","volume":"9","author":"Barco","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.lpm.2024.104248_bib0065","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027514","article-title":"Cost-of-illness analysis of long-term health care resource use and disease burden in patients with pulmonary embolism: insights from the PREFER in VTE registry","volume":"11","author":"Farmakis","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.lpm.2024.104248_bib0066","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jama.2019.8594","article-title":"Pulmonary embolism hospitalization, readmission, and mortality rates in US older adults, 1999-2015","volume":"322","author":"Bikdeli","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2024.104248_bib0067","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1160\/TH17-08-0531","article-title":"Acute pulmonary embolism in a national danish cohort: increasing incidence and decreasing mortality","volume":"118","author":"Lehnert","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104248_bib0068","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","article-title":"Global burden of thrombosis: epidemiologic aspects","volume":"118","author":"Wendelboe","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.lpm.2024.104248_bib0069","doi-asserted-by":"crossref","DOI":"10.1093\/ehjqcco\/qcae050","article-title":"Estimated annual healthcare costs after acute pulmonary embolism: results from a prospective multicentre cohort study","author":"Mohr","year":"2024","journal-title":"Eur Heart J Qual Care Clin Outcomes"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498224000277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498224000277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T01:46:51Z","timestamp":1737596811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498224000277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0755498224000277"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2024.104248","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing the management of acute intermediate-high-risk pulmonary embolism: The enduring legacy of Professor Guy Meyer","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2024.104248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104248"}}